Formulation of pH-sensitive aminated chitosan–gelatin crosslinked hydrogel for oral drug delivery

The objective of this study is to develop efficient pH-sensitive hydrogel based on aminated chitosan (AmCs) and gelatin (Gel) biopolymers for oral drug delivery. Herein, AmCs was chemically crosslinked with gelatin (Gel) biopolymer with different ratios, while their structures, thermal profiles and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ahmed Mohamed Omer, Wagih Abdel-Alim Sadik, Abdel-Ghaffar Maghraby El-Demerdash, Heba Shawky Hassan
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/35a5a0740ce74504bdb31d6c8bad9d0f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:35a5a0740ce74504bdb31d6c8bad9d0f
record_format dspace
spelling oai:doaj.org-article:35a5a0740ce74504bdb31d6c8bad9d0f2021-11-18T04:45:55ZFormulation of pH-sensitive aminated chitosan–gelatin crosslinked hydrogel for oral drug delivery1319-610310.1016/j.jscs.2021.101384https://doaj.org/article/35a5a0740ce74504bdb31d6c8bad9d0f2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1319610321001897https://doaj.org/toc/1319-6103The objective of this study is to develop efficient pH-sensitive hydrogel based on aminated chitosan (AmCs) and gelatin (Gel) biopolymers for oral drug delivery. Herein, AmCs was chemically crosslinked with gelatin (Gel) biopolymer with different ratios, while their structures, thermal profiles and morphological properties were investigated by FTIR, TGA and SEM characterization tools, respectively. Moreover, gel-content, crosslinking density and rheological analysis were also performed. The results clarified that the developed AmCs-Gel crosslinked hydrogel displayed variable pH-sensitive swelling profiles. By increasing AmCs ratio, the swelling ratio was boosted at pH 1.2 and declined at pH 7.4. Besides, by increasing gelatin ratio in the hydrogel matrix, the loading efficiency of Oseltamivir phosphate (as a model of drug) was augmented and reached maximum value of 79.0% by AmCs-Gel (2:3) crosslinked hydrogel. The in vitro drug release profiles were investigated for 6 h in simulated gastric fluid [SGF; pH 1.2] and simulated colon fluid [SCF; pH 7.4]. Variable release profiles were realized depending on variation of AmCs and Gel ratios in the crosslinked hydrogel matrix. Finally, the formulated smart crosslinked AmCs-Gel hydrogels demonstrated acceptable biodegradability with no cellular toxicity, suggesting their applicability as pH-sensitive oral drug carriers.Ahmed Mohamed OmerWagih Abdel-Alim SadikAbdel-Ghaffar Maghraby El-DemerdashHeba Shawky HassanElsevierarticleAminated chitosanGelatinDrug releasepH-sensitive hydrogelChemistryQD1-999ENJournal of Saudi Chemical Society, Vol 25, Iss 12, Pp 101384- (2021)
institution DOAJ
collection DOAJ
language EN
topic Aminated chitosan
Gelatin
Drug release
pH-sensitive hydrogel
Chemistry
QD1-999
spellingShingle Aminated chitosan
Gelatin
Drug release
pH-sensitive hydrogel
Chemistry
QD1-999
Ahmed Mohamed Omer
Wagih Abdel-Alim Sadik
Abdel-Ghaffar Maghraby El-Demerdash
Heba Shawky Hassan
Formulation of pH-sensitive aminated chitosan–gelatin crosslinked hydrogel for oral drug delivery
description The objective of this study is to develop efficient pH-sensitive hydrogel based on aminated chitosan (AmCs) and gelatin (Gel) biopolymers for oral drug delivery. Herein, AmCs was chemically crosslinked with gelatin (Gel) biopolymer with different ratios, while their structures, thermal profiles and morphological properties were investigated by FTIR, TGA and SEM characterization tools, respectively. Moreover, gel-content, crosslinking density and rheological analysis were also performed. The results clarified that the developed AmCs-Gel crosslinked hydrogel displayed variable pH-sensitive swelling profiles. By increasing AmCs ratio, the swelling ratio was boosted at pH 1.2 and declined at pH 7.4. Besides, by increasing gelatin ratio in the hydrogel matrix, the loading efficiency of Oseltamivir phosphate (as a model of drug) was augmented and reached maximum value of 79.0% by AmCs-Gel (2:3) crosslinked hydrogel. The in vitro drug release profiles were investigated for 6 h in simulated gastric fluid [SGF; pH 1.2] and simulated colon fluid [SCF; pH 7.4]. Variable release profiles were realized depending on variation of AmCs and Gel ratios in the crosslinked hydrogel matrix. Finally, the formulated smart crosslinked AmCs-Gel hydrogels demonstrated acceptable biodegradability with no cellular toxicity, suggesting their applicability as pH-sensitive oral drug carriers.
format article
author Ahmed Mohamed Omer
Wagih Abdel-Alim Sadik
Abdel-Ghaffar Maghraby El-Demerdash
Heba Shawky Hassan
author_facet Ahmed Mohamed Omer
Wagih Abdel-Alim Sadik
Abdel-Ghaffar Maghraby El-Demerdash
Heba Shawky Hassan
author_sort Ahmed Mohamed Omer
title Formulation of pH-sensitive aminated chitosan–gelatin crosslinked hydrogel for oral drug delivery
title_short Formulation of pH-sensitive aminated chitosan–gelatin crosslinked hydrogel for oral drug delivery
title_full Formulation of pH-sensitive aminated chitosan–gelatin crosslinked hydrogel for oral drug delivery
title_fullStr Formulation of pH-sensitive aminated chitosan–gelatin crosslinked hydrogel for oral drug delivery
title_full_unstemmed Formulation of pH-sensitive aminated chitosan–gelatin crosslinked hydrogel for oral drug delivery
title_sort formulation of ph-sensitive aminated chitosan–gelatin crosslinked hydrogel for oral drug delivery
publisher Elsevier
publishDate 2021
url https://doaj.org/article/35a5a0740ce74504bdb31d6c8bad9d0f
work_keys_str_mv AT ahmedmohamedomer formulationofphsensitiveaminatedchitosangelatincrosslinkedhydrogelfororaldrugdelivery
AT wagihabdelalimsadik formulationofphsensitiveaminatedchitosangelatincrosslinkedhydrogelfororaldrugdelivery
AT abdelghaffarmaghrabyeldemerdash formulationofphsensitiveaminatedchitosangelatincrosslinkedhydrogelfororaldrugdelivery
AT hebashawkyhassan formulationofphsensitiveaminatedchitosangelatincrosslinkedhydrogelfororaldrugdelivery
_version_ 1718425031335215104